Abbott Molecular Inc. is a genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases.
Company Growth (employees)
Type
Public
HQ
Illinois City, US
Founded
1991
Size (employees)
74,000 (est)-1%
Website
abbott.com
Abbott was founded in 1991 and is headquartered in Illinois City, US

Key People at Abbott

Miles D. White

Miles D. White

CEO
Thomas C. Freyman

Thomas C. Freyman

CFO
Stephen Fussell

Stephen Fussell

Executive Vice President, Human Resources

Abbott Office Locations

Abbott has offices in Illinois City, Sao Paulo, Shanghai, Beijing and in 5 other locations
Illinois City, US (HQ)
Abbott Park
Québec, CA
8401 Trans Canada Highway, Saint Laurent
Maidenhead, GB
Abbott House, Vanwall Business Park, Vanwall Road
Wiesbaden, DE
Abbott Gmb H & Co. Kg, Max Planck Ring 2
Seoul, KR
Samtan Bldg., 3rd Floor, 421 Young Dong Daero, Kangnam Ku
Tokyo, JP
3 5 27, Mita, Minato Ku
Beijing, CN
17 F, Canway Builing, No. 66 Nanlishi Road
Shanghai, CN
23 F/26 F/27 F/28 F/32 F/33 F/36 F/37 F/39 F, Ciro’s Plaza, No. 388 West Nanjing Road
Sao Paulo, BR
Rua Michigan, 735 – Brooklin

Abbott Metrics

Abbott Financial Metrics

Revenue (2016)

$20.9 b

Revenue growth (2015-16), %

2%

Gross profit

$11.8 b

Gross profit margin (2016), %

57%

Net income (2016)

$1.4 b

Market capitalization (28-Apr-2017)

$75.4 b

Closing share price (28-Apr-2017)

$43.7

Cash (31-Dec-2016)

$18.6 b
Abbott's current market capitalization is $75.4 b.
Abbott's revenue was reported to be $20.9 b in FY, 2016 which is a 2% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$21.8 b$20.2 b$20.4 b$20.9 b

Revenue growth, %

(7%)1%2%

Cost of goods sold

$10 b$9.2 b$8.7 b$9 b

Gross profit

$11.8 b$11 b$11.7 b$11.8 b

Gross profit Margin, %

54%54%57%57%

Operating expense total

$9.2 b$17.6 b$17.5 b$17.7 b

EBIT

$2.6 b$2.6 b$2.9 b$3.2 b

EBIT margin, %

12%13%14%15%

Interest expense

$157 m$150 m$163 m$431 m

Interest income

$67 m$77 m$105 m$99 m

Income tax expense

$53 m$797 m$577 m$350 m

Net Income

$2.6 b$2.3 b$4.4 b$1.4 b
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$3.5 b$4.1 b$5 b$18.6 b

Accounts Receivable

$4 b$3.6 b$3.4 b$3.2 b

Inventories

$2.7 b$2.6 b$2.6 b$2.4 b

Current Assets

$19.2 b$15.3 b$14.2 b$26.8 b

PP&E

$12.9 b$12.6 b$12.4 b$12.4 b

Goodwill

$9.8 b$10.1 b$9.6 b$7.7 b

Total Assets

$43 b$41.3 b$41.2 b$52.7 b

Accounts Payable

$1 b$1.1 b$1.1 b$1.2 b

Dividends Payable

$341 m$362 m$383 m$391 m

Total Debt

$6.6 b$7.8 b$9 b$22 b

Current Liabilities

$9.5 b$10.5 b$9.2 b$6.7 b

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.4 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$2.6 b$2.3 b$4.4 b$1.4 b

Accounts Receivable

$113 m$195 m$171 m$177 m

Inventories

($154 m)($297 m)($257 m)($98 m)

Accounts Payable

$256 m$225 m$742 m$652 m

Cash From Operating Activities

$3.3 b$3.7 b$3 b$3.2 b

Purchases of PP&E

$1.1 b$1.1 b$1.1 b$1.1 b

Cash From Investing Activities

$3.9 b($202 m)$406 m$248 m

Short-term Borrowings

$1.3 b$1.8 b

Long-term Borrowings

$303 m$577 m$2.5 b$14.9 b

Dividends Paid

($882 m)($1.3 b)($1.4 b)($1.5 b)

Cash From Financing Activities

$6.7 b$2.7 b$2.2 b$11.1 b

Interest Paid

$148 m$182 m$166 m$181 m

Income Taxes Paid

$1 b$448 m$631 m$620 m

Abbott Operating Metrics

FY, 2014FY, 2015FY, 2016

Products

10 k1.5 k1.5 k

New Product Launches

38

Abbott Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
AlereApril 15, 2017$5.3 b
St. Jude MedicalApril 28, 2016$25 b
Kalila MedicalApril 06, 2016
AlereFebruary 02, 2016$5.8 b

Abbott Market Value History

Abbott Online Presence

Abbott Company Life

You may also be interested in